Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.

× No keyword cloud information.

16 in total

Review 1. Clinical applications of hallucinogens: A review.

Authors: Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal: Exp Clin Psychopharmacol Date: 2016-08 Impact factor: 3.157

2. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Authors: David Wyndham Lawrence; Robin Carhart-Harris; Roland Griffiths; Christopher Timmermann
Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996

Review 3. New Paradigms of Old Psychedelics in Schizophrenia.

Authors: Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal: Pharmaceuticals (Basel) Date: 2022-05-23

Review 4. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Authors: Ede Frecska; Attila Szabo; Michael J Winkelman; Luis E Luna; Dennis J McKenna
Journal: J Neural Transm (Vienna) Date: 2013-04-26 Impact factor: 3.575

Review 5. Neuropharmacology of N,N-dimethyltryptamine.

Authors: Theresa M Carbonaro; Michael B Gatch
Journal: Brain Res Bull Date: 2016-04-25 Impact factor: 4.077

Review 6. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

Authors: Botond Penke; Livia Fulop; Maria Szucs; Ede Frecska
Journal: Curr Neuropharmacol Date: 2018 Impact factor: 7.363

Review 7. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors: Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal: Front Psychiatry Date: 2017-08-18 Impact factor: 4.157

Review 8. Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Authors: Attila Szabo
Journal: Front Immunol Date: 2015-07-14 Impact factor: 7.561

9. Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.

Authors: Attila Szabo; Attila Kovacs; Ede Frecska; Eva Rajnavolgyi
Journal: PLoS One Date: 2014-08-29 Impact factor: 3.240

Review 10. The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization.

Authors: Ede Frecska; Petra Bokor; Michael Winkelman
Journal: Front Pharmacol Date: 2016-03-02 Impact factor: 5.810